Since the COVID-19 pandemic, Björkman has focused on designing immunogens to stimulate antibody responses against coronaviruses.

Pamela Björkman, an American biochemist at the California Institute of Technology, has been awarded the prestigious Wolf Prize for her groundbreaking research on treatments for HIV and coronaviruses.

The Wolf Prize, awarded annually for 47 years, recognizes outstanding achievements in the arts and sciences, with many winners later receiving Nobel Prizes.

The Wolf Fund recognized her for providing 'new hope in the fight against infectious diseases' through her innovative research.

In addition to Björkman, this year's Wolf Prize in architecture was awarded to Chinese architect Tiantian Xu for her transformative rural development projects in China.

Her research has significantly advanced the understanding of the immune system's response to pathogens, particularly in T-cell recognition and immunization strategies.

This year's architecture prize went to Tiantian Xu for her impactful work, which has significantly transformed local economies and cultures.

Her work has been highlighted as a promising strategy for developing future vaccines aimed at major immunization challenges.

Other notable recipients of the 2025 Wolf Prize include Jeffery Dangl, Jonathan Jones, and Brian Staskawicz, recognized for their contributions in agriculture, physics, and chemistry.

Notable past laureates of the Wolf Prize include Stephen Hawking and Marc Chagall, underscoring the award's prestigious history.

Xu's projects have economically and socially revitalized villages through innovative designs, contrasting with conventional urban development strategies.

The Wolf Fund praised Björkman's work as a new rational design strategy for future vaccines against major infectious diseases.